Concepedia

Sudha S. Shankar

SS

Statistics

Publications

30

Citations

2.2K

H-Index

21

Active since

2002

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

Eli Lilly (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Pfizer (United States)

Sudha S. Shankar is an author at Indiana University – Purdue University Indianapolis specializing in medicine, diabetes mellitus, and endocrinology.

ORCID

Publications per year

2002–2024

30

Publications

30

Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation

Ahmed Tawakol, Zahi A. Fayad, Robin Mogg et al. · Journal of the American College of Cardiology · 2013 · 412 citations

, , +16

Regulation of Adiponectin Expression in Human Adipocytes: Effects of Adiposity, Glucocorticoids, and Tumor Necrosis Factor α

Mikako Degawa‐Yamauchi, Katherine A. Moss, Jason E. Bovenkerk et al. · Obesity Research · 2005 · 201 citations

, , +11

High nitric oxide production in autistic disorder: a possible role for interferon-γ

Thayne L. Sweeten, David J. Posey, Sudha S. Shankar et al. · Biological Psychiatry · 2003 · 174 citations

, , +13

Treatment with <scp>LY</scp> 2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes

Cristina B. Guzmán, Xiaotian Michelle Zhang, Rong Liu et al. · Diabetes Obesity and Metabolism · 2017 · 165 citations

, , +17

Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease

Diana Barb, Enrico Repetto, Michael Edward Stokes et al. · Obesity · 2021 · 144 citations · Full text

, , +16

1–5 of 30